¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myocardial infarct imaging"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • cine magnetic resonance imaging
    ¿µÈ­ÀÚ±â°ø¸í¿µ»ó
  • chemical shift imaging
    È­Çк¯À§¿µ»ó
  • dynamic imaging
    ¿ªµ¿¿µ»ó, µ¿¿µ»ó
  • diffusion tensor imaging
    È®»êÅÙ¼­¿µ»ó
  • diffusion weighted imaging
    È®»ê°­Á¶¿µ»ó
  • fast imaging technique
    °í¼Ó¿µ»ó±â¹ý
  • frequency modulation imaging
    Á֯ļöº¯Á¶¿µ»ó
  • functional magnetic resonance imaging
    ±â´ÉÀÚ±â°ø¸í¿µ»ó¹ý
  • gradient acquisition imaging
    ±â¿ï±âȹµæ¿µ»ó
  • gradient echo imaging
    ±â¿ï±â¿¡ÄÚ¿µ»ó
  • gradient refocused imaging
    ±â¿ï±âÀçÃÊÁ¡¿µ»ó
  • hybrid imaging
    È¥ÇÕ¿µ»ó
  • intravoxel coherent motion imaging
    È­Àû¼Ò³»°áÁý¿îµ¿¿µ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocardial siderosis
    ½ÉÀå±ÙÀ°Ã¶Ä§ÂøÁõ
  • myocardial stimulant
    ½É±ÙÀÚ±ØÁ¦, °­½ÉÁ¦
  • myocardial perfusion scintigraphy
    ½É±ÙÁÖ»ç¼ú, ½ÉÀå±ÙÀ°¼¶±¤Á¶¿µ¼ú
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • multislice imaging acquisition
    ´ÙÁßÀýÆí¿µ»óȹµæ
  • chemical shift imaging
    È­Çк¯À§¿µ»ó
  • cine magnetic resonance imaging
    ¿µÈ­ÀÚ±â°ø¸í¿µ»ó
  • diffusion tensor imaging
    È®»êÅÙ¼­¿µ»ó
  • diffusion weighted imaging
    È®»ê°­Á¶¿µ»ó
  • dynamic imaging
    ¿ªµ¿¿µ»ó, µ¿¿µ»ó
  • fast imaging technique
    °í¼Ó¿µ»ó±â¹ý
  • frequency modulation imaging
    Á֯ļöº¯Á¶¿µ»ó
  • gradient acquisition imaging
    ±â¿ï±âȹµæ¿µ»ó
  • gradient echo imaging
    ±â¿ï±â¿¡ÄÚ¿µ»ó
  • gradient refocused imaging
    ±â¿ï±âÀçÃÊÁ¡¿µ»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • imaging
    ¿µ»ó
  • imaging gradient
    ¿µ»ó °æ»ç(ÀÚ°è)
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging of STIR sequence
    STIR ¿¬¼â ¿µ»ó
  • imaging parameter
    ¿µ»ó ÁöÇ¥, ¿µ»ó º¯¼ö
  • imaging procedure
    ¿µ»ó ÀýÂ÷
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • phase offset multiplannar (POMP) imaging
    À§»ó ¿ÀÇÁ¼Â ´Ù¸é ¿µ»ó
  • radionuclide imaging
    ¹æ»ç¼º ÇÙÁ¾À̸ÞÀÌ¡.
  • real time imaging
    ½Ç½Ã°£ ¿µ»ó ±â¹ý
  • receptor imaging
    ¼ö¿ëü¿µ»ó(È­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lateral myocardial infarction
    Ãøº®½É±Ù°æ»ö(ö°ÛúãýÐÉÌãßá).
  • myocardiac,myocardial
    ½É±ÙÀÇ
  • myocardial
    ½É±Ù(ãýÐÉ)ÀÇ.
  • myocardial anoxia
    ½É±Ù¹«»ê¼ÒÁõ(ãýÐÉÙíß«áÈñø).
  • myocardial biospy
  • myocardial bridging
    ½É±Ù±³¶ô.
  • myocardial contractility
    ½É±Ù¼öÃ༺.
  • myocardial contractility
    ½É±Ù¼öÃà·Â
  • myocardial contraction
    ½É±Ù¼öÃà(¡­â¥õê).
  • myocardial contusion
    ½É±ÙÁ»ó(¡­ñ©ß¿).
  • myocardial damage
    ½É±ÙÀå¾Ö, ½É±Ù¼Õ»ó(¡­áßß¿).
  • myocardial degeneration
    ½É±Ùº¯¼º(¡­Ü¨àõ).
  • myocardial degeneration
    ½É±Ùº¯¼º(ãýÐÉܨàõ)
  • myocardial depressant
    ½É(±Ù)¾ïÁ¦¾à(¡­åäð¤å·), ½É±Ù¾ïÁ¦Á¦.
  • myocardial depressant
    ½É±Ù¾ïÁ¦Á¦, ½É(±Ù)¾ïÁ¦¾à(¡­åäð¤å·).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fractional echo imaging
    ºÐÇÒ¿¡ÄÚ¿µ»ó
  • frequency modulation imaging
    Á֯ļöº¯Á¶¿µ»ó
  • functional brain imaging
    ±â´ÉÀû³ú¿µ»ó
  • functional magnetic resonance imaging [=fMRI]
    ±â´ÉÀûÀÚ±â°ø¸í¿µ»ó
  • gradient acquisition imaging
    °æ»çȹµæ¿µ»ó
  • gradient echo [=GRE] imaging
    °æ»ç¿¡ÄÚ¿µ»ó
  • gradient refocused imaging
    °æ»çÀçÃÊÁ¡¿µ»ó
  • half Fourier imaging
    ¹ÝFourier¿µ»ó
  • hybrid imaging
    È¥¼º¿µ»ó
  • imaging
    ¿µ»ó
  • imaging gradient
    ¿µ»ó°æ»ç(ÀÚ°è)
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging of STIR sequence
    STIR¿¬¼â¿µ»ó
  • imaging parameter
    ¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
  • imaging procedure
    ¿µ»óÀýÂ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MPI mannose phosphate isomerase; master patient index; maximum permitted intake; maximum point of impuls...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AMI acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial...
IMI immunologically measurable insulin; impending myocardial infarction; Imperial Mycological Institute ...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MB Myocardial Bridge
MDF Myocardial Depressant Factor
MVO2 Myocardial O2 consumption
MBF Myocardial blood flow
MCF Myocardial contractile force
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • functional brain imaging
    ±â´ÉÀû ³ú ¿µ»ó
  • hybrid imaging
    È¥¼º ¿µ»ó
  • imaging
    ¿µ»ó, ¿µ»óÈ­
    »ó¿¡¼­, ƯÈ÷ X¼±°ú ÃÊÀ½ÆÄ »ó¿¡¼­ ¼±¸í, ´ëÁ¶ ¹× »ó¼¼¼ºÀ» »ý¼ºÇÏ´Â °Í. ¹æ»ç¼± »çÁø, ÃÊÀ½ÆÄ, ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ ±×¸®°í Àڱ⠰ø¸í»ó°ú °°ÀÌ Áø´Ü ¸ñÀûÀ¸·Î ±¸Á¶¹°À» º¸¿©Áְųª À̸¦ ½Ã°¢ÀûÀ¸·Î ÀçÇü¼ºÇÑ °Í.
  • imaging modality
    ¿µ»ó ¹æ½Ä
  • imaging parameter
    ¿µ»ó ÁöÇ¥, ¿µ»ó º¯¼ö
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • intravoxel coherent motion imaging
    º¹¼¿³» °áÁý ¿îµ¿ ¿µ»ó
  • magnetization transfer imaging
    ÀÚÈ­ Àü´Þ ¿µ»ó
  • multiecho imaging
    ´ÙÁß ¿¡ÄÚ ¿µ»ó
  • multiphase cardiac imaging
    ´ÙÁß À§»ó ½ÉÀå ¿µ»ó
  • partial echo imaging
    ºÎºÐ ¿¡ÄÚ ¿µ»ó
  • partial volume imaging
    ºÎºÐ ¿ëÀû ¿µ»ó
  • perfusion and diffusion imaging
    °ü·ù È®»ê ¿µ»ó
  • radionuclide imaging
    ¹æ»ç¼º ÇÙÁ¾ »ó
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
myocardial infarction in dumbbell form Infarction involving the septum along with both inferior and anterior walls to make an H-or dumbbell-shaped configuration.
Synonym: Roesler-Bressler infarct.
(05 Mar 2000)
myocardial insufficiency A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
myocardial ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (coronary arteriosclerosis), to obstruction by a thrombus (coronary thrombosis), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).
(12 Dec 1998)
myocardial necrosis Irreversible destruction of myocardial (heart muscle) cells.
(27 Sep 1997)
myocardial reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury.
(12 Dec 1998)
myocardial reperfusion injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion.
(12 Dec 1998)
myocardial revascularization The restoration of blood supply to the myocardium.
(12 Dec 1998)
myocardial rigor mortis Irreversible contraction of the left ventricle of the heart as a complication seen in the early period of cardiopulmonary bypass and now avoided by appropriate cardioplegic solutions.
Synonym: myocardial rigor mortis, stone heart.
(05 Mar 2000)
myocardial stunning Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue.
(12 Dec 1998)
posterior myocardial infarction Infarction involving the posterior wall of the heart; also formerly used erroneously of infarction's involving the inferior or diaphragmatic surface of the heart.
(05 Mar 2000)
silent myocardial infarction Infarction that produces none of the characteristic symptoms and signs of myocardial infarction.
(05 Mar 2000)
subendocardial myocardial infarction Infarction that involves only the layer of muscle subjacent to the endocardium.
(05 Mar 2000)
nontransmural myocardial infarction Necrosis of heart muscle that fails to extend from the endocardium to the epicardium, often erroneously considered relatively benign.
(05 Mar 2000)
diaphragmatic myocardial infarction Infarction in which the inferior or diaphragmatic wall of the heart is involved, producing indicative changes in leads II, III, and aVF in the electrocardiogram.
Synonym: diaphragmatic myocardial infarction.
(05 Mar 2000)
inferior myocardial infarction Infarction in which the inferior or diaphragmatic wall of the heart is involved, producing indicative changes in leads II, III, and aVF in the electrocardiogram.
Synonym: diaphragmatic myocardial infarction.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á